ROBERT BRESALIER to Female
This is a "connection" page, showing publications ROBERT BRESALIER has written about Female.
Connection Strength
0.338
-
Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Res. 2016 09 29; 18(1):97.
Score: 0.016
-
A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells. Cancer. 2011 Oct 01; 117(19):4375-80.
Score: 0.011
-
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer. 2007 Feb 15; 109(4):668-74.
Score: 0.008
-
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology. 2007 Feb; 132(2):490-7.
Score: 0.008
-
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Res. 2005 Dec 01; 65(23):10767-75.
Score: 0.008
-
Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci. 2005 Jul; 330(1):11-8.
Score: 0.007
-
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005 Mar 17; 352(11):1092-102.
Score: 0.007
-
Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian Cancers. Discov Med. 2024 Mar; 36(182):632-645.
Score: 0.007
-
Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct. Pathol Res Pract. 2023 Jul; 247:154546.
Score: 0.006
-
Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions. PLoS One. 2021; 16(11):e0258878.
Score: 0.006
-
Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures. Clin Chim Acta. 2020 Aug; 507:39-53.
Score: 0.005
-
A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade. J Transl Med. 2019 12 19; 17(1):424.
Score: 0.005
-
Rate of colorectal neoplasia in patients with Hodgkin lymphoma. Colorectal Dis. 2020 02; 22(2):154-160.
Score: 0.005
-
Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial. Am J Clin Nutr. 2019 10 01; 110(4):903-911.
Score: 0.005
-
Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors. Scand J Gastroenterol. 2019 May; 54(5):538-545.
Score: 0.005
-
Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps. Dig Dis Sci. 2019 10; 64(10):2965-2971.
Score: 0.005
-
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2019 04 02; 7(1):93.
Score: 0.005
-
Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. J Transl Med. 2019 02 28; 17(1):61.
Score: 0.005
-
Body mass index, calcium supplementation and risk of colorectal adenomas. Int J Cancer. 2019 02 01; 144(3):448-458.
Score: 0.005
-
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflamm Bowel Dis. 2018 07 12; 24(8):1695-1705.
Score: 0.005
-
Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Br J Dermatol. 2018 08; 179(2):337-344.
Score: 0.005
-
Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial. Gut. 2019 03; 68(3):475-486.
Score: 0.005
-
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer. 2018 01; 118(1):52-61.
Score: 0.004
-
Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology. 1997 Aug; 113(2):455-64.
Score: 0.004
-
Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial. JAMA Oncol. 2017 May 01; 3(5):628-635.
Score: 0.004
-
Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog. 2017 08; 56(8):1977-1983.
Score: 0.004
-
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Gastroenterology. 2017 06; 152(8):1933-1943.e5.
Score: 0.004
-
Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults. J Nutr. 2016 Nov; 146(11):2312-2324.
Score: 0.004
-
Randomized controlled trials: who fails run-in? Trials. 2016 07 29; 17:374.
Score: 0.004
-
Association between adenoma location and risk of recurrence. Gastrointest Endosc. 2016 Oct; 84(4):709-16.
Score: 0.004
-
Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc. 2016 Aug; 84(2):315-25.
Score: 0.004
-
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med. 2015 Oct 15; 373(16):1519-30.
Score: 0.004
-
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prev Res (Phila). 2015 Dec; 8(12):1131-7.
Score: 0.004
-
Risk Factors for Hemorrhoids on Screening Colonoscopy. PLoS One. 2015; 10(9):e0139100.
Score: 0.004
-
Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prev Res (Phila). 2015 Nov; 8(11):1061-8.
Score: 0.004
-
Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc. 2015 Sep; 82(3):512-9.
Score: 0.004
-
Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial. J Gen Intern Med. 2015 Oct; 30(10):1447-53.
Score: 0.004
-
Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control. 2015 Mar; 26(3):377-86.
Score: 0.004
-
The association of age and race and the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):448-53.
Score: 0.004
-
Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med. 1994 Oct 15; 121(8):568-75.
Score: 0.004
-
Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014; 9(10):e108094.
Score: 0.004
-
Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014 Oct; 99(10):E2133-7.
Score: 0.004
-
Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis. 2013 Nov; 57(10):1384-92.
Score: 0.003
-
Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med. 2013 Jun; 2(3):391-402.
Score: 0.003
-
CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control. 2013 Jan; 24(1):47-54.
Score: 0.003
-
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012 Jun 21; 366(25):2345-57.
Score: 0.003
-
Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc. 2012 Mar; 75(3):612-20.
Score: 0.003
-
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst. 2012 Feb 22; 104(4):280-9.
Score: 0.003
-
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila). 2012 Apr; 5(4):574-82.
Score: 0.003
-
Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiol. 2012 Aug; 36(4):395-9.
Score: 0.003
-
Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16.
Score: 0.003
-
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75.
Score: 0.003
-
Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer. 2010 Sep; 46(13):2457-66.
Score: 0.003
-
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010 Apr 21; 102(8):538-46.
Score: 0.003
-
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010 Mar 15; 116(6):1454-61.
Score: 0.003
-
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark. 2010-2011; 8(2):109-12.
Score: 0.003
-
A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc. 2010 Mar; 71(3):551-6.
Score: 0.003
-
Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst. 2009 Dec 02; 101(23):1650-4.
Score: 0.003
-
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2726-33.
Score: 0.003
-
Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1041-9.
Score: 0.002
-
Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76.
Score: 0.002
-
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila). 2008 Dec; 1(7):507-13.
Score: 0.002
-
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila). 2008 Nov; 1(6):470-5.
Score: 0.002
-
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet. 2008 Nov 15; 372(9651):1756-64.
Score: 0.002
-
Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2625-31.
Score: 0.002
-
Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr. 2007 Nov; 137(11):2443-50.
Score: 0.002
-
Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med. 1987 Sep 28; 83(3B):110-6.
Score: 0.002
-
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9.
Score: 0.002
-
An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res. 1987 Mar 01; 47(5):1398-406.
Score: 0.002
-
Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study. Am J Clin Nutr. 2006 Nov; 84(5):1184-92.
Score: 0.002
-
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology. 2006 Dec; 131(6):1674-82.
Score: 0.002
-
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97.
Score: 0.002
-
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol. 2006 Jun; 1(5):478-86.
Score: 0.002
-
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer. 2006 Feb 01; 106(3):552-8.
Score: 0.002
-
Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):306-11.
Score: 0.002
-
Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer. 2006 Jan 15; 106(2):287-96.
Score: 0.002
-
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol. 2006 Jan 10; 24(2):259-67.
Score: 0.002
-
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2006 Jan; 131(1):65-72.
Score: 0.002
-
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S11-5.
Score: 0.002
-
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer. 2005 Oct 15; 104(8):1620-6.
Score: 0.002
-
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst. 2005 Jul 06; 97(13):989-97.
Score: 0.002
-
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41.
Score: 0.002
-
CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis. 2005 Jun; 26(6):1122-8.
Score: 0.002
-
Hemochromatosis gene mutations and distal adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):158-63.
Score: 0.002
-
Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr. 2004 Nov; 80(5):1358-65.
Score: 0.002
-
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004 Oct; 78(4):1152-60; discussion 1152-60.
Score: 0.002
-
Dysplasia in Barrett esophagus. Cancer. 2004 Apr 15; 100(8):1622-7.
Score: 0.002
-
Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA. 2003 Jul 02; 290(1):41-8.
Score: 0.002
-
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003 May 03; 361(9368):1491-5.
Score: 0.002
-
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 06; 348(10):891-9.
Score: 0.002
-
Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol. 2003 Mar; 1(2):103-10.
Score: 0.002
-
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer. 2002 May 15; 94(10):2569-76.
Score: 0.002
-
Histoplasmosis presenting as the carpal tunnel syndrome. Am J Surg. 1981 Feb; 141(2):286-8.
Score: 0.001
-
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000 Dec; 21(6 Suppl):273S-309S.
Score: 0.001